Complaints and Recalls. (a) Licensed Product Complaints. Proprius, at Proprius’ own expense, or as applicable, a Sublicensee at its own expense, shall investigate, respond to and take all appropriate corrective or other actions regarding all complaints associated with the manufacture and/or distribution of Licensed Products which are made, used, distributed or sold by or on behalf of Proprius or any of its Sublicensees in accordance with all applicable laws.
Complaints and Recalls. (a) Hospira shall notify Abbott promptly of any Product complaints involving Xxxxxx’x manufacture in sufficient time to allow Abbott to evaluate the complaints and assist Hospira in responding to such complaints.
Complaints and Recalls. 5.01 Have written procedures in place to document, investigate, and respond to all quality related complaints.
Complaints and Recalls. In the event that a Product delivered by Syntagon is involved in any complaint from Oasmia customers or contract producer of an Oasmia registered pharmaceutical product, Oasmia shall immediately inform Syntagon and provide all necessary information to Syntagon to, in a timely manner, initiate all required investigations. Further, Syntagon shall be immediately informed of any complaints or regulatory action, investigation or recall on Oasmia products from regulatory authorities. Syntagon shall collaborate with Oasmia at its best efforts to provide all required information to Oasmia. Recalls proven to be caused by negligence from Syntagon shall be remedied by Syntagon in accordance with Section 13. Any non conformance, regulatory actions or complaints to Syntagon, by other than Oasmia, Syntagon shall without any delay inform Oasmia. Syntagon shall make all efforts possible to minimize the effect of such events.
Complaints and Recalls. (a) Complaints. Drug Product complaints received by Client with respect to Drug Product Manufactured by Company hereunder shall be sent to Company within the time period set forth in the Quality Agreement, after receipt to: Alcami Corporation Attention: Corporate Quality 0000 Xxxxxxxxxx Xxxx Xxxxx Xxxxxxxxxx, XX 00000 Facsimile No.: (000) 000-0000 Email: xxxxxxx.xxxxxxxxxx@xxxxxxxxx.xxx As more fully described in the Quality Agreement, Company shall investigate all complaints directly associated with the Manufacture of Drug Product(s) and shall provide an update every [*] and a report to Client regarding its investigation and any conclusions. Client shall investigate all other complaints associated with the Drug Product(s).
Complaints and Recalls. 16 6.6 PUBLICITY..................................................... 16 ARTICLE VII.............................................................. 17
Complaints and Recalls. Insulet shall manage all complaints, failure analysis and recalls related to the Product in the Territory in a commercially reasonably manner. In the event of a recall or potential recall of the Product in the Territory, Insulet shall notify and consult with TheraSense with regard to the measures to be taken consistent with good business practice. Such undertaking shall be at Insulet's expense; provided, however, that if the cause of such complaint, failure or recall is a flaw that is also present in the FreeStyle Meter or the Test Strips, then TheraSense shall reimburse Insulet for all reasonable costs incurred. TheraSense shall render commercially reasonable support and information to assist Insulet in managing any complaints, failures or recalls related to the Test Strips or the functioning of the Test Strips with the Remote Controller.
Complaints and Recalls. If Alliant receives a complaint or information regarding a Licensed Product which it would be required under applicable Law to disclose to a Regulatory Agency, it shall promptly, but in any event not later than twenty-four (24) hours after receipt, advise BioMarin in writing of the details of such complaint or information. Promptly thereafter, Alliant shall report such complaint or information to the appropriate Regulatory Agencies in the countries in North America, respectively, in which such Licensed Product is being commercialized, each as may be required by, and in accordance with, the appropriate Laws of the relevant countries and Regulatory Agencies. Alliant shall provide to BioMarin with all available follow-up information related to such incident (including any information in such Party’s possession as may be reasonably required by the other Party to satisfy its regulatory filing obligations).
Complaints and Recalls. 9.1 Each Party shall notify the other Party immediately by telephone and confirm in writing within twenty four (24) hours upon becoming aware of any problem relating to the Product, including where:
Complaints and Recalls. 11.1 NxStage shall be responsible for initial handling of customer complaints relat-ing to the Products and shall give prompt written notice to PISA of the same. PISA shall then take prompt action to make such internal investigations as are called for in the circumstances and report its findings to NxStage.
